ÂÜÀòÂÒÂ×

Ray Jupp is the CSO of Mestag Therapeutics. Prior to this Ray was CSO of Enara Bio. Prior to joining Enara Bio, Ray was the founding CSO of TRex Bio, a discovery stage company focused on the functional manipulation of T-regulatory cells in a tissue-specific and disease-specific fashion to deliver transformative therapies for multiple disease indications. Previously, Ray was head of the Immunology/Inflammation therapeutic area at UCB where he drove multiple compounds into development and through phase 1 and 2 trials. Ray has also held research and development leadership roles at Sanofi, Aventis, Rhone-Poulenc Rorer and Roche, where he developed deep expertise in the fields of inflammation, immunology, and infectious disease. Ray graduated with a PhD in Biochemistry from Cardiff University, followed by a post-doctoral fellowship at the Scripps Research Institute, San Diego.